Tirofiban administration and percutaneous coronary intervention with stenting of saphenous vein graft thrombosis

Claudia D'andrea1, Giovanni Esposito, Federico Piscione

  • 1Department of Clinical Medicine, Cardiovascular Sciences and Immunology, Federico II University, Naples, Italy.

Insights

A 48-hour tirofiban infusion effectively reduced thrombus burden in a saphenous vein graft lesion, enabling successful percutaneous coronary intervention (PCI) without distal protection devices. This approach offers a feasible alternative for managing complex SVG disease.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Percutaneous coronary intervention (PCI) for saphenous vein graft (SVG) lesions carries a high risk of distal embolization, leading to myonecrosis and myocardial infarction.
  • Current guidelines recommend distal embolic protection devices during PCI for SVG disease, but alternative strategies remain underexplored.

Observation:

  • An 84-year-old male presented with acute coronary syndrome due to an occluded SVG with significant endoluminal thrombosis and poor distal flow.
  • A management strategy involving a 48-hour upstream tirofiban infusion was employed to reduce thrombus burden prior to PCI.

Findings:

  • Tirofiban administration resulted in substantial thrombus resolution and improved coronary blood flow.
  • Successful PCI with stenting was achieved without the use of a distal protection device.
  • The patient experienced no periprocedural ischemia and remained asymptomatic.

Implications:

  • Preprocedural tirofiban administration followed by PCI may be a safe and effective strategy for treating thrombotic SVG lesions, particularly when distal protection devices are not feasible.
  • This approach could offer a viable alternative for patients with degenerated SVG disease.
  • Further research is warranted to validate these findings in larger patient cohorts.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...